Yaqin Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI).
Journal: Frontiers in pharmacology
Published: May 25, 2026
Baseline Liver Fibrosis Severity Predicts Superior HBeAg Clearance and Fibrosis Reversal following Peg-IFNα plus Nucleos(t)ide Analog Therapy in HBeAg-positive Chronic Hepatitis B Patients.
Journal: Journal of clinical and translational hepatology
Published: February 27, 2026
Analysis of risk factors and establishment of a predictive model for liver disease severity in metabolic dysfunction-associated fatty liver disease.
Journal: Frontiers in medicine
Published: February 07, 2026
The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment.
Journal: Frontiers in cellular and infection microbiology
Published: January 11, 2026
The Application of Nanomaterials in the Detection of Liver Cancer Biomarkers.
Journal: International journal of nanomedicine
Published: January 10, 2026
Clinically Optimized Adult Height Prediction From Key Bone and Pubertal Stages: Prospective Validation to Adult Height.
Journal: Journal of the Endocrine Society
Published: October 19, 2025
COVID-19 Infection, Drugs, and Liver Injury.
Journal: Journal of clinical medicine
Published: July 28, 2025
Association between changes in HBsAb levels and hepatic adverse events after HBsAg clearance in non-cirrhotic chronic hepatitis B patients.
Journal: BMC infectious diseases
Published: July 13, 2025
Progress in the Application of Nanobiotechnology in the Ablation Therapy of Hepatic Carcinoma.
Journal: International journal of nanomedicine
Published: July 07, 2025
Last Updated: 09/26/2026